Description

Pink Star Pellets 5-MAPB 70mg / 2-FMA 20mg / 5-MeO-MiPT 2mg: Premium Industrial Grade Research Formulation

Product Details Table

 

Thank you for reading this post, don't forget to subscribe!

---

Pink Star Combination Pellets | Multi-Compound Research Formulation | BioSynLab

BioSynLab presents Pink Star combination pellets, a complex multi-compound research formulation containing 5-MAPB (70mg), 2-FMA (20mg), and 5-MeO-MiPT (2mg) for advanced polypharmacological research and drug interaction studies. This combination research chemical serves as a critical tool for investigating serotonergic-aminergic-tryptaminergic interactions, polydrug pharmacodynamics, and forensic analytical characterization of novel psychoactive substance (NPS) combinations.

Chemical Composition & Polypharmacological Profile

Pink Star pellets represent a three-component research formulation combining distinct pharmacological classes:

Component 1: 5-MAPB (70mg)

• Chemical Class: Benzofuran entactogen (MDMA analog)
• Mechanism: Serotonin, norepinephrine, and dopamine release; 5-HT2A partial agonism
• IUPAC Name: 1-(benzofuran-5-yl)-N-methylpropan-2-amine
• Role in Formulation: Primary serotonergic/entactogenic component

Component 2: 2-FMA (20mg)

• Chemical Class: Fluorinated amphetamine stimulant
• Mechanism: Norepinephrine and dopamine reuptake inhibition; TAAR1 agonism
• IUPAC Name: 1-(2-fluorophenyl)-N-methylpropan-2-amine
• Role in Formulation: Aminergic stimulant component

Component 3: 5-MeO-MiPT (2mg)

• Chemical Class: Substituted tryptamine psychedelic
• Mechanism: 5-HT1A/5-HT2A receptor agonism
• IUPAC Name: 5-methoxy-N-methyl-N-isopropyltryptamine
• Role in Formulation: Serotonergic psychedelic component

Combined Pharmacological Effects:

• Serotonin modulation: Triple mechanism (release + reuptake inhibition + receptor agonism)
• Monoamine interaction: Complex catecholaminergic effects
• Potential for synergistic toxicity: Serotonin syndrome risk, cardiovascular stress

Pellet Formulation & Manufacturing Specifications

Our combination pellets utilize advanced formulation technology ensuring homogeneous distribution of three distinct APIs:

Formulation Composition:

• 5-MAPB: 70.0mg (28.0% w/w)
• 2-FMA: 20.0mg (8.0% w/w)
• 5-MeO-MiPT: 2.0mg (0.8% w/w)
• Microcrystalline cellulose: 130.0mg (52.0% w/w)
• Pregelatinized starch: 25.0mg (10.0% w/w)
• Magnesium stearate: 2.5mg (1.0% w/w)
• FD&C Red #3: 0.5mg (0.2% w/w)

Physical Specifications:

• Hardness: 6-8 kp (resistant to breakage)
• Friability: <0.3% (minimal dust generation)
• Content uniformity: RSD <8% per component (challenging with 2mg dose)
• Disintegration: 30-45 minutes (simulated gastric fluid)

Quality Control:

• HPLC verification: Each component quantified individually
• Homogeneity testing: Stratified sampling across batch
• Stability: Accelerated and real-time testing for three-component system

Analytical Characterization & Multi-Component Verification

Each Pink Star pellet batch undergoes comprehensive analytical profiling for all three components:

Chromatographic Analysis:

• HPLC-DAD (UV): Three-component separation and quantification
  • 5-MAPB: 280nm retention time ~8.5 min
  • 2-FMA: 220nm retention time ~6.2 min
  • 5-MeO-MiPT: 280nm retention time ~12.8 min
• LC-MS/MS confirmation:
  • 5-MAPB: [M+H]⁺ m/z 190.1
  • 2-FMA: [M+H]⁺ m/z 168.1
  • 5-MeO-MiPT: [M+H]⁺ m/z 247.2

Content Verification:

• 5-MAPB: 70mg ± 5mg (±7%)
• 2-FMA: 20mg ± 2mg (±10%)
• 5-MeO-MiPT: 2mg ± 0.2mg (±10%)

Physical Testing:

• Weight variation: RSD <5%
• Dissolution: >75% for each component within 60 minutes
• Identity: FTIR per component (reference spectrum matching)

Research Applications & Forensic Significance

Pink Star combination pellets serve specific research functions:

Forensic Toxicology:

• NPS combination detection method development
• Street drug analysis reference material
• Polydrug toxicity modeling
• Drug signature profiling (linking seizures to sources)

Pharmacological Research:

• Drug-drug interaction studies (three-way combinations)
• Serotonin syndrome mechanism research
• Cardiovascular stress modeling (sympathomimetic + serotonergic)
• Thermoregulatory dysfunction studies

Analytical Chemistry:

• Multi-component quantification method validation
• Chromatographic separation optimization
• Mass spectrometry library construction
• Colorimetric/presumptive test interference studies

Public Health Research:

• Polydruse use patterns analysis
• Harm reduction education materials
• Emergency department toxicology reference
• Mortality/morbidity association studies

Global Distribution & Restricted Supply

BioSynLab provides strictly controlled distribution for combination research chemicals:

Eligibility Requirements:

• Forensic laboratory certification (preferred)
• DEA Schedule I research registration (USA)
• Controlled drug license (UK/EU)
• Institutional verification and research protocol review

Packaging & Shipping:

• Cryogenic packaging: -20°C with data loggers
• Discrete outer packaging: No chemical nomenclature
• Documentation: Import/export permits, customs declarations
• Insurance: Full value coverage

Service Coverage (Licensed Institutions Only):

United Kingdom: London, Manchester, Birmingham, Leeds, Glasgow, Liverpool, Sheffield, Bristol, Edinburgh, Cardiff.

European Union: Berlin, Hamburg, Munich, Cologne, Frankfurt, Amsterdam, Rotterdam, Paris, Lyon, Barcelona, Madrid, Rome, Milan.

North America: New York, Los Angeles, Chicago, Houston, Philadelphia, San Antonio, San Diego, Dallas, San Jose.

---